Orthofix Medical (OFIX)
NASDAQ:OFIX
Want to see OFIX full AI Analyst Report?
Earnings Data
Report Date
Aug 11, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.39Last Year’s EPS
-0.36Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed steady, disciplined execution with several clear operational and commercial positives: modest top-line growth in Q1, strong performance among top distributors, outperformance in Therapeutic Solutions, improving gross margin, a healthy innovation pipeline (7D, TrueLok Elevate, Fitbone, VIRATA) and reaffirmed full-year guidance. At the same time, challenges persist—Biologics remains soft, U.S. Limb Reconstruction growth was flat, absolute EBITDA was modest, and some results were influenced by timing, mix and prior commercial transitions. Management emphasized that distributor transitions are largely behind them and discussed focused leadership changes and product launches to drive acceleration through the year. Overall, the positives and negatives are balanced, with evidence of improving momentum but meaningful operational work still required.Company Guidance
Total Net Sales and Quarterly Growth
Q1 2026 total global net sales of $196.4 million, up 3% year-over-year on a pro forma constant currency basis (adjusted to exclude discontinued M6 product lines).
Spine Fixation Momentum
Global Spine Fixation net sales grew 6% (constant currency) with U.S. Spine up 4%; distributor transitions largely complete and improved field execution supporting continued acceleration.
Top Distributor Performance
Top 30 U.S. distributor partners delivered standout growth: net sales +27% year-over-year and +24% on a trailing-12-month basis, demonstrating success of prioritizing larger, dedicated distributors.
Therapeutic Solutions Outperformance
Therapeutic Solutions (BGT) net sales of $57.8 million, up 5% year-over-year; fracture sales grew 6% and the business continues to outperform the broader market with improving utilization and prescribing activity.
Product Innovation and Pipeline
Full-year contribution expected from TrueLok Elevate and Fitbone, 7D FLASH navigation remains a differentiator, and VIRATA full-market launch scheduled for H2 2026 (with MIS alpha launch). Innovation pipeline cited as a key driver of multi-year growth.
Margin Expansion and Profitability Trajectory
Pro forma non-GAAP adjusted gross margin improved to 70.7%, a 40 basis point increase versus prior year; full-year non-GAAP adjusted EBITDA guidance of $95–$98 million implies ~70 bps of margin expansion at the midpoint.
Liquidity and Cash Position
Ended Q1 with $120.9 million in total cash (including restricted cash) and management expects positive free cash flow for full year 2026 (excluding potential legal settlements).
Reaffirmed 2026 Guidance and Improving Cadence
Reaffirmed full-year net sales guidance of $850–$860 million (~5.5% pro forma constant currency growth midpoint) with first-half growth ~5% and second-half growth ~6%, signaling expected acceleration through the year.
OFIX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OFIX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $12.01 | $12.44 | +3.58% |
Feb 24, 2026 | $13.59 | $12.75 | -6.18% |
Nov 04, 2025 | $16.06 | $14.87 | -7.41% |
Jun 30, 2025 | $11.09 | $11.15 | +0.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Orthofix Medical (OFIX) report earnings?
Orthofix Medical (OFIX) is schdueled to report earning on Aug 11, 2026, After Close (Confirmed).
What is Orthofix Medical (OFIX) earnings time?
Orthofix Medical (OFIX) earnings time is at Aug 11, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OFIX EPS forecast?
OFIX EPS forecast for the fiscal quarter 2026 (Q2) is -0.39.